Stage 4 lung cancer survivor: Why I joined a targeted therapy clinical trial at UT MD Anderson
I work in the pharmaceutical industry with a drug that treats Parkinson¡¯s disease symptoms, so I¡¯m familiar with the drug-vetting process. Just because a drug hasn¡¯t been approved yet by the Food and Drug Administration (FDA) doesn¡¯t necessarily mean it¡¯s not safe or effective ¡ª it just means it¡¯s still being studied in anticipation of approval.
So, when my UT MD Anderson thoracic medical oncologist, Dr. Eric Singhi, offered me...